Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

From traditional medicine to innovation: Discovering novel analgesics targeting calcium modulation from Cameroonian phytochemicals

$3.61M USD

Funder NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH
Recipient Organization University of Kentucky
Country United States
Start Date Sep 17, 2024
End Date Aug 31, 2026
Duration 713 days
Number of Grantees 3
Roles Co-Investigator; Principal Investigator
Data Source NIH (US)
Grant ID 10986264
Grant Description

PROJECT SUMMARY/ABSTRACT There is a pressing need to identify and validate new targets for chronic pain and new sources for novel compounds. This proposal will use novel extracts and pure compounds from multiple Cameroonian plants namely Paullinia pinnata, Petersianthus macrocarpus and Acacia sieberiana to probe the biology and therapeutic

potential of an exciting non-opioid target for pain, focusing on calcium homeostasis especially through sigma 2 (σ-2) (aka transmembrane protein 97 (TMEM97)). “Agonists” for σ-2/TMEM97 reduce neuropathic and inflammatory pain in mice. Our primary research goal is to use a focused interdisciplinary approach to isolate

bioactive compounds from traditional medicine and utilize these new tools in Cameroon to address research and education disparities that contribute to poor pain outcomes in Central Africa. This goal will be pursued with a unique collaboration that we have developed between researchers at the University of Dschang (Cameroon; Dr.

Nguelefack), the University of Texas at Dallas (USA; Dr. Kolber) and the University of Kentucky (USA; Dr. Tidgewell). Preliminarily, the Nguelefack lab has shown that crude extracts of P. Pinnata, P. macrocarpus and A. sieberiana significantly decrease inflammatory and neuropathic pain in rats. The Tidgewell/Kolber groups

have shown that the methanol extracts of P. pinnata show in vitro binding affinity to σ-2/TMEM97 and modulate primary sensory neurons. This proposal will utilize our interdisciplinary and international approach with in vitro evaluation of plant extracts, followed by fractionation, in vitro testing of σ-2/TMEM97 binding, and additional in

vitro validation at UT Dallas and Dschang with pure compounds. In addition to the research focus on Ca2+ homeostasis, this proposal aims to build research and clinical capacity for the study of pain in Cameroon and surrounding countries. This will be accomplished using a mixture of capacity building initiatives including the

training of Cameroon trainees in the US and Cameroon, the building of Dschang University as a center for pain research in central Africa, and the hosting of local workshops at Dschang to support the spread of research knowledge in Cameroon and surrounding countries.

All Grantees

University of Kentucky

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant